Key result
Transcriptomic meta-analysis identifies a consensus transcriptional signature revealing conserved disease patterns in end-stage HF.
Why the study?
Agreement on key regulated genes in HF is limited and systematic efforts to integrate evidence from multiple patient cohorts are lacking.
Meta-Analysis (n=916)
This study provides a robust consensus transcriptional signature of human end-stage heart failure by integrating 16 public datasets, offering a free public resource for identifying novel diagnostic or therapeutic targets.
May inform novel HF diagnostic or therapeutic targets; leaves open clinical translation pending validation.
Abstract Aims Transcriptomic studies have contributed to fundamental knowledge of myocardial remodeling in human heart failure (HF). However, the agreement on key regulated genes in HF is limited and systematic efforts to integrate evidence from multiple patient cohorts are lacking. Here we aimed to provide an unbiased consensus transcriptional signature of human end-stage HF by comprehensive comparison and analysis of publicly available datasets. Methods and Results We curated and uniformly processed 16 public transcriptomic studies of left ventricular samples from 263 healthy and 653 failing human hearts. Transfer learning approaches revealed conserved disease patterns across all studies independent of technical differences. We meta-analyzed the dysregulation of 14041 genes to extract a consensus signature of HF. Estimation of the activities of 343 transcription factors, 14 signalling pathways, and 182 micro RNAs, as well as the enrichment of 5998 biological processes confirmed the established aspects of the functional landscape of the disease and revealed novel ones. We provide all results in a free public resource https://saezlab.shinyapps.io/reheat/ to facilitate further use and interpretation of the results. We exemplify usage by deciphering fetal gene reprogramming and tracing myocardial origin of the plasma proteome biomarkers in HF patients. Conclusion We demonstrated the feasibility of combining transcriptional studies from different HF patient cohorts. This compendium provides a robust and consistent collection of molecular markers of end-stage HF that may guide the identification of novel targets with diagnostic or therapeutic relevance.
No takes yet. Share an insight, caveat, or question.
Flores et al. (2020) conducted a meta-analysis in End-stage heart failure (n=916). End-stage heart failure vs. Healthy non-failing hearts was evaluated on Consensus transcriptional signature of human end-stage heart failure. A meta-analysis of 16 transcriptomic studies comprising 916 samples identified a consensus transcriptional signature of human end-stage heart failure, revealing conserved disease patterns independent of technical differences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: